Navigation Links
Educating the Marketplace Through Collaborations with Patient Advocacy Groups

CHAPEL HILL, N.C., May 18 /PRNewswire/ -- Patient and professional advocacy groups are an integral part of educating the marketplace on new medicines. Effectively collaborating with advocacy groups is fundamental for educating the public on treatment options and is especially critical for socially sensitive conditions/therapies. "Collaborating with Patient Advocacy Groups to Educate the Marketplace" is a 125-page report from Best Practices, LLC that identifies successful tactics and strategies for working with patient advocacy groups and managing relationships.

Download a complimentary report summary, including sample best practices drawn from extensive primary research with executives at leading companies:

In addition to providing a road map for effective collaborations with advocacy groups, this Best Practices, LLC research project also examines ideal structures and skill sets for pharma groups that deal with advocacy groups. Fifty-eight advocacy leaders from 43 companies such as Abbott, Wyeth, Genentech, Novartis, Bayer, Amgen, Astellas, Takeda and J&J shared their practices and insights into advocacy group collaborations. More than a dozen organizations participated in deep-dive interviews to provide actionable insights into working with the advocacy world.

Key topics of this report include:

  • Understanding the Advocacy Landscape
  • Managing Advocacy Relationships
  • Managing Relationships with Hostile Groups
  • Structuring High Performance Biopharma Advocacy Groups
  • Using New Technologies
  • Current Trends and Future Directions

Executives, directors and managers at device, pharmaceutical and biotech organizations who work in patient advocacy functions can use this research to compare their group's approaches and tactics for advocacy group interactions against those of leading organizations.

To learn more about Best Practices' other timely research visit: or contact Jeff Zimmer at 919-767-9180 or


Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for 17 years; our clients include 46 out of the top 50 pharmaceutical companies. For more information visit:

SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. UCSF and YouTube Launch Channel Dedicated to Educating the Public About Neurodegenerative Diseases
2. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
3. International Substance Detection Firm IDenta To Release New Lead Test Kit - Rash Of Toy Incidents Leads Company To Enter New Marketplace
4. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
5. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
6. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
7. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
8. Micromet, Inc. Fills Audit Committee Vacancy and Regains Compliance With NASDAQ Marketplace Rule
9. Extraordinary General Meetings Statement - XTL Notifies NASDAQ of Compliance with Marketplace Rule 4350(d)(2)
10. Marketplace Streamlines M&A Process for Technology Businesses
11. Vasogen Complies with NASDAQ Marketplace Rule 4350(c)(1)
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... ... the year and one of the premier annual events for pharmaceutical manufacturing: 2015 ... 8–11 November 2015, where ISPE hosted the largest number of attendees in more ...
(Date:11/24/2015)... 2015 --> ... "Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, ... DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) ... market is expected to reach USD 1,918.6 Million by ... CAGR of 10.1% during the forecast period. ...
(Date:11/24/2015)... SHPG ) announced today that Jeff Poulton , ... Annual Healthcare Conference in New York City ... (1:30 p.m. GMT). --> SHPG ) announced today that ... Piper Jaffray 27 th Annual Healthcare Conference in ... at 8:30 a.m. EST (1:30 p.m. GMT). --> Shire ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... that the remaining 11,000 post-share consolidation (or 1,100,000 ... (the "Series B Warrants") subject to the previously ... November 23, 2015, which will result in the ... effect to the issuance of such shares, there ...
Breaking Biology Technology:
(Date:11/18/2015)... 18, 2015 --> ... new market report titled  Gesture Recognition Market - Global ... - 2021. According to the report, the global gesture recognition market was ... to reach US$29.1 bn by 2021, at a CAGR ... North America dominated the global gesture recognition ...
(Date:11/16/2015)... Calif. , Nov 16, 2015  Synaptics ... of human interface solutions, today announced expansion of ... TouchView ™ touch controller and display driver ... revolution of smartphones. These new TDDI products add ... TD4100 (HD resolution), TD4302 (WQHD resolution), and TD4322 ...
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
Breaking Biology News(10 mins):